Status:
COMPLETED
Repeatability in Hyperpolarized 3-Helium With MRI
Lead Sponsor:
Eric A. Hoffman
Conditions:
Radiation Exposure
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
The main purpose of this study is to assess and test the reproducibility and results of hyperpolarized 3-Helium gas as a contrast agent with Magnetic Resonance Imaging (MRI) of the lungs in healthy ad...
Detailed Description
New CT imaging techniques often expose the patient to higher doses of radiation. There is a great deal of concern about effects of medical radiation exposure on the general public and regulations are ...
Eligibility Criteria
Inclusion
- must be between the ages of 18 and 90
- must have a Body Mass Index (BMI) of \< 32 and weigh \< 200 lbs.
Exclusion
- if female, must not be pregnant or breastfeeding
- must not have any metal objects in or on their body including body piercings that cannot be easily removed, bullets, metallic fragments or slivers in eyes, skin, etc., pacemaker or defibrillation, aneurysm clips, cochlear implants, coronary stents, or neurostimulation.
- must not have a history of claustrophobia, panic disorders, anxiety attacks, atrial fibrillation, uncontrolled high blood pressure, frequent ventricular ectopic rhythm, hemodynamic instability, kidney dysfunction or heart disease.
Key Trial Info
Start Date :
July 22 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03776747
Start Date
July 22 2008
End Date
June 1 2012
Last Update
November 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa
Iowa City, Iowa, United States, 52242